GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs $48.03

down -0.34


1/8/2014 04:05 PM  |  NYSE : GSK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get GSK Trend Analysis - it has underperformed the S&P 500 by 20%

Partner Headlines

  1. Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab

    Benzinga
  2. A Look at the Week's Top Dividend Growers

    GuruFocus
  3. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  4. GlaxoSmithKline

    IBD
  5. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  6. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR ...

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  9. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  10. British Stocks: Sweet Spot For European Value

    YCharts
  11. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  12. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  13. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech ...

    Benzinga
  14. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  15. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering ...

    Benzinga
  16. Major British Companies Lead Top Guru-Held UK and Ireland Stocks

    GuruFocus
  17. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  18. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  19. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  20. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  21. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  22. Can Pfizer Make Up Its Loss?

    GuruFocus
  23. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  24. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  25. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  26. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing GDP And ...

    Benzinga
  27. Glaxo hurt by Advair scandal

    IBD
  28. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  29. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  30. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  31. China Rule Change Further Opens Yuan To World Markets

    IBD
  32. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  33. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine for ...

    Benzinga
  34. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  35. Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical ...

    Benzinga
  36. Big Pharmas Swap Specialties

    IBD
  37. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  38. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  39. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  40. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  41. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  42. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  43. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  44. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  45. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  46. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  47. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  48. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  49. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  50. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
Trading Center